Skip to main content
Log in

Granulomatous Hepatitis Following Intravesical Bacillus Calmette-Guerin Therapy

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Although intravesical bacillus Calmette-Guerin (BCG) administration is an effective method in the treatment of superficial urinary bladder carcinoma, some complications may arise such as a granulomatous reaction either in the urinary tract or, in rare cases, outside the urinary tract. We report in this paper a case of granulomatous hepatitis following intravesical BCG administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lamm, D. L.: Bacillus Calmette-Guerin immunotherapy for bladder cancer. J. Urol., 134, 40 (1985).

    PubMed  Google Scholar 

  2. Brosman, S. A.: The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ. J. Urol., 134, 36 (1985).

    PubMed  Google Scholar 

  3. Orihuela, E., Herr, H. W., Pinsky, C. M., Whitmore, W. F.: Toxicity of intravesical BCG and its management in patients with superficial bladder tumours. Cancer, 60, 326 (1987).

    PubMed  Google Scholar 

  4. Lamm, D. L., Stogdill, V. D., Stogdill, B. J., Crispen, R. G.: Complications of bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer. J. Urol., 135, 272 (1986).

    PubMed  Google Scholar 

  5. Graziano, D. A., Jacobs, D., Lozano, R. G., Buck, R. L.: A case of granulomatous hepatitis after intravesical bacillus Calmette-Guerin administration. J. Urol., 146, 1118 (1991).

    PubMed  Google Scholar 

  6. Lamm, D. L., Van Der Meijden, P. M., Morales, A., Brosman, S. A., Catalona, W. J., Herr, H. W., Soloway, M. S., Steg, A., Debruyne, F. M. J.: Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J. Urol., 147, 596 (1992).

    PubMed  Google Scholar 

  7. Marans, H. Y., Bekirov, H. M.: Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma. J. Urol., 137, 111 (1987).

    PubMed  Google Scholar 

  8. Molina, J. M., Rabian, C., Dagay, M. F., Modai, J.: Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: Successful treatment with steroids. J. Urol., 147, 695 (1995).

    Google Scholar 

  9. Proctor, D. D., Chopra, S., F. A. C. G., Rubenstein, S. C., Jokela, J. A., Uhl, L.: Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma. Am. J. Gastroenterology, 88, 1112 (1993).

    Google Scholar 

  10. Morales, A.: Long-term results and complications of intracavitary bacillus Calmette-Guerin therapy for bladder cancer. J. Urol., 132, 457 (1984).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Özbakkaloğlu, B., Tünger, Ö., Sürücüoğlu, S. et al. Granulomatous Hepatitis Following Intravesical Bacillus Calmette-Guerin Therapy. Int Urol Nephrol 31, 49–53 (1999). https://doi.org/10.1023/A:1007119706336

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007119706336

Keywords

Navigation